Episode Details

Back to Episodes

World-Class Science. But Where Are Australia’s Biotechs?

Published 4 weeks, 2 days ago
Description

Our guest is Dr. Bob Soh, a partner at Brandon Capital, Australia’s biggest life sciences venture capital firm.

Bob talks with Rui Yip about why Australia’s strong research base hasn’t produced a bigger biotech industry, and why overseas biotechs often run their Phase 1 trials here. They also cover how veterans of big pharma are helping launch new companies, how the local pool of biotech venture capital is growing, and what’s being done to keep promising companies, manufacturing and know-how in the country as they scale.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us